JENNIFER YEAMAN: Open Payments
NPI 1770123655 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 25 payments from 14 companies in 2025. Trend: 2023 $435 · 2024 $788 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Radius Health, Inc. | 3 | $75 |
| PFIZER INC. | 3 | $64 |
| Astellas Pharma US Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novo Nordisk Inc | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $22 |
Products named: Tymlos, NURTEC ODT, CREON, Veozah, UBRELVY, AIRSUPRA, QULIPTA, GEMTESA.
Industry payments across OK — which companies pay providers there.
